Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

China Issues Draft Opinion on Anti-Bribery and Antitrust Requirements for Pharmaceutical Market Access

Alert May 2020

  • News and Insights
  • China Issues Draft Opinion on Anti-Bribery and Antitrust Requirements for Pharmaceutical Market Access

China Issues Draft Opinion on Anti-Bribery and Antitrust Requirements for Pharmaceutical Market Access

May 2020, Covington Alert

On April 13, 2020, China’s National Healthcare Security Administration (“NHSA”) released a draft opinion titled “Guiding Opinions on Establishment of a Drug Pricing and Procurement Creditworthiness System (the “Draft Opinion”; Covington’s translation is available here) setting forth proposed requirements for a creditworthiness evaluation and disciplinary system for companies that want to participate in centralized drug procurement and bidding activities.

View More

Related Professionals

Share links:

Share links:

Related Practices

Related Offices

Related Regions

Related News & Insights